CliffBio
small molecule

SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE

MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE

Loss of exclusivity—loss of exclusivity
CompanyTaro Pharmaceutical Industries →See this company's full patent-cliff portfolio

Drug detail

Brand nameSODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE
Active ingredientMAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE
Strength1.6GM/BOT;3.13GM/BOT;17.5GM/BOT
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalMarch 2024
Marketing statusRX

More from Taro Pharmaceutical Industries

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.